Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hepcidin, hepcidin antagonists and methods of use

Hepcidin, hepcidin antagonists and methods of use

US Patent 8629250 · Granted Jan 14, 2014

Estimated economic value: $174,160,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific T cell engagers2025
Method of treatment using anti-CD19 rituximab-resistant chimeric antigen recepto2025
Protease-activating CD45-gate CAR2025
Bispecific antagonist comprising a LAG-3 binding domain2025
Checkpoint regulator antagonists2025
Chimeric antigen receptors targeting FLT32025
Bispecific antibody construct directed to MUC17 and CD32025
Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Methods of manufacturing allogeneic CAR T cells2024
Chimeric antigen receptors targeting CD702024
Human CGRP receptor binding proteins2024
Human CGRP receptor binding proteins2024